EmrE is a small multidrug transporter in Escherichia coli that extrudes various positively charged drugs across the plasma membrane in exchange with protons, thereby rendering cells resistant to these compounds. Biochemical experiments indicate that the basic functional unit of EmrE is a dimer where the common binding site for protons and substrate is formed by the interaction of an essential charged residue (Glu-14) from both EmrE monomers. Carbodiimide modification of EmrE has been studied using functional assays, and the evidence suggests that Glu-14 is the target of the reaction. Here we exploited electrospray ionization mass spectrometry to directly monitor the reaction with each monomer rather than following inactivation of the functional unit. A cyanogen bromide peptide containing Glu-14 allows the extent of modification by the carboxylspecific modification reagent diisopropylcarbodiimide (DiPC) to be monitored and reveals that peptide 2 NPY-IYLGGAILAEVIGTTLM 21 is ϳ80% modified in a time-dependent fashion, indicating that each Glu-14 residue in the oligomer is accessible to DiPC. Furthermore, preincubation with tetraphenylphosphonium reduces the reaction of Glu-14 with DiPC by up to 80%. Taken together with other biochemical data, the findings support a "time sharing" mechanism in which both Glu-14 residues in a dimer are involved in tetraphenylphosphonium and H ؉ binding.
EmrE, 1 an Escherichia coli multidrug resistance protein, provides a unique model for the study of polytopic membrane proteins. It is a small (110-residue) multidrug transporter that extrudes various positively charged drugs in exchange for protons, thus rendering bacteria resistant to these drugs (Fig. 1, A and B) (1) (2) (3) . The protein has been characterized, purified, and reconstituted in a functional form (1, 4 -6) . High affinity substrate binding has been established as a reliable and sensitive assay for activity of the detergent-solubilized transporter (4) . Structural and biochemical evidence suggests that the basic EmrE oligomer is a dimer (7) (8) (9) (10) . EmrE has only one membrane-embedded charged residue, Glu-14, which is conserved in more than 100 homologous proteins (5) . Acidic side chains embedded in the membrane have been shown to be important for activity in various ion-coupled transporters (for a review, see Ref. 11) . In some cases, these acidic side chains are involved in substrate recognition and binding; in others, they comprise part of the coupling ion translocation pathway. EmrE is unique in that the same acidic side chain (the carboxyl group of is involved in recognition of both substrate and the coupling ion. Furthermore, because replacement of the two other acidic side chains in EmrE (E25C/D84C) 2 does not detrimentally effect the activity of the protein, it is concluded that the only carboxyl group required for catalysis is that of Glu-14 (12, 13) .
Within the small multidrug resistance family of transporters, a comparative analysis reveals that the face of transmembrane domain 1 containing Glu-14 is conserved, displaying a helical periodicity. Site-directed mutagenesis of this transmembrane domain 1 face identifies a cluster of five amino acids that play a role in substrate and H ϩ recognition and/or translocation, with substitutions at most positions yielding either inactive mutants or mutants with modified affinity to substrates (14) . Correspondingly, a homologue of EmrE from the archaeon Halobacterium salinarum (Hsmr) is built of over 40% valine and alanine residues and remains relatively unaltered on the face containing Glu-14. However, Val and Ala residues are clustered on the face opposite Glu-14 in domains that do not seem important for activity (15) .
Previously, we have shown that the hydrophobic carbodiimides (carboxyl-specific modification reagents) dicyclohexylcarbodiimide and diisopropylcarbodiimide (DiPC) inhibit the binding and transport of substrates by EmrE (13), whereas dimethylaminopropyl-N-ethylcarbodiimide (EDAC), a hydrophilic carbodiimide, does not. Moreover, because dicyclohexylcarbodiimide also inactivated an EmrE mutant containing only a single carboxyl residue at position 14, it was inferred that * This work was supported in part by National Institutes of Health Grants NS16708 (to S. S.) and DK51131:07 (to H. R. K.) and by Grant 2003-309 from the United States Israel Binational Science Foundation, Jerusalem, Israel. The Pasarow family and the W. M. Keck Foundation provided partial funds for instrument purchase. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Glu-14 is covalently modified by the carbodiimide (12) . However, no information was available as to the number of Glu-14 residues reacting in the functional unit. In the present study, by exploiting the ability of reverse phase (RP)-high performance liquid chromatography (HPLC) in conjunction with ESI-MS to resolve complex mixtures (16 -18) , it was directly demonstrated that Glu-14 is modified by DiPC. Moreover, tetraphenylphosphonium (TPP ϩ ) reduces modification of Glu-14 by ϳ80%, indicating that both Glu-14 residues in the functional unit are close enough to the binding site that TPP ϩ prevents their modification or that they might be equivalently protected in an allosteric manner by TPP ϩ . These observations are not consistent with a recent mechanistic model based on threedimensional crystals diffracting to 3.8 Å (19) . In this model, the functional unit of EmrE is a dimer of structural heterodimers. However, within each heterodimer the two Glu-14s are in structurally distinct positions leading to functionally distinct roles in proton and substrate translocation. The observations presented here are more consistent with a "time-sharing" model where the Glu-14 residues in both monomers are in a similar environment, have similar reactivity to carbodiimides, and are both involved in substrate and proton recognition.
MATERIALS AND METHODS
Bacterial Strains and Plasmids-E. coli TA15 (20) was used for EmrE expression. Cells were transformed with plasmid pGP1-2, which encodes for the regulated expression of T7 polymerase under the inducible control of the P L promoter (21) . The plasmids used for EmrE gene expression are pT7-7 (21) derivatives with the hexahistidine tag using a Myc epitope as linker (4) . Throughout this report, for simplicity, Mycand His-tagged protein is named EmrE. E25C, D84C, and E25C/D84C-EmrE (SC-EmrE, single carboxyl construct) mutants were previously characterized (12, 13) .
Overexpression and Purification of EmrE-E. coli TA15 cells that bear plasmids pGP1-2 and pT7-7 containing His-tagged EmrE constructs were grown at 30°C in minimal medium A supplemented with 2.5 g/ml thiamine, 0.5% glycerol, 100 g/ml ampicillin, and 50 g/ml kanamycin. When the culture reached A 600 ϭ 1, the temperature was elevated rapidly to 42°C to allow for T7 polymerase expression for 15 min and then was decreased to 30°C. Two hours later the cells were harvested by centrifugation and washed once with buffer containing 150 mM NaCl, 15 mM Tris, pH 7.5, 250 mM sucrose before storage at Ϫ70°C. For membrane preparation, cells were resuspended in the same buffer containing 2.5 mM MgSO 4 , 1 mM dithiothreitol, 15 g/ml DNaseI, and 1 mM phenylmethylsulfonyl fluoride (5 ml of buffer/g cells). Membranes were prepared by disrupting the cells using a Microfluidics microfluidizer processor (M-110EHi). Nondisrupted cells were discarded by centrifugation (4225 ϫ g for 5 min at 4°C), and the membranes were collected by centrifugation at 240,000 ϫ g for 90 min at 4°C. The membrane pellet was washed and resuspended in 150 mM NaCl, 15 mM Tris, pH 7.5, 250 mM sucrose, 1 mM phenylmethylsulfonyl fluoride, and 1 mM dithiothreitol (membrane protein concentration ϳ20 mg/ml), frozen in liquid air, and stored at Ϫ70°C. Wild type EmrE and the mutants were purified by solubilizing membranes (ϳ5 mg of protein/ml) in 1% DDM, 150 mM NaCl, 15 mM Tris-HCl, pH 7.5, 50 mM imidazole, pH 7.5, and 1 mM phenylmethylsulfonyl fluoride for 40 min at 25°C. Unsolubilized material was removed by centrifugation at 240,000 ϫ g for 45 min at 4°C. In the case of single carboxyl-EmrE, ␤-mercaptoethanol (15 mM) was added throughout purification to prevent cysteine cross-linking.
The solubilized protein was loaded on a HiTrap TM chelating HP column (Amersham Biosciences) mounted on an Akta Explorer (Amersham Biosciences) and washed with 0.08% DDM, 150 mM NaCl, 15 mM Tris-HCl, and 50 mM imidazole, pH 7.5 till A 280 of the flowthrough decreased below 0.05. EmrE was eluted with a gradient of up to 300 mM imidazole. Major peak fractions were pooled, and the protein solution was brought to ϳ5 mg/ml EmrE (according to A 280 ). The protein stock was aliquoted, frozen in liquid air, and stored at Ϫ70°C.
Carbodiimide Labeling and Sample Preparation for Size Exclusion HPLC of Full-length EmrE or RP-HPLC of CNBr
Fragments-DiPC and EDAC were freshly prepared as 1 M stocks dissolved in Me 2 SO and water, respectively. After dialysis of purified protein in 50 mM NaP i (pH 6.5), 100 mM NaCl, 0.02% DDM, the protein was reacted with DiPC or EDAC at 30°C for a given time and immediately precipitated with CHCl 3 /MeOH as described (22) . An aliquot (100 l) of the aqueous protein solution at a concentration of 1-2 mg/ml was diluted 1:3 (v/v) with MeOH and mixed briefly. CHCl 3 (100 l) was added and mixed, yielding a single phase. 
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Phase separation was accomplished by adding water (200 l) and mixing vigorously. The phases were separated by centrifugation (10000 ϫ g for 2 min), yielding a precipitate at the interface. Although EmrE is soluble in CHCl 3 /MeOH (1:1, v/v), at the ratio used here it was possible to isolate the precipitate by rapidly removing the bulk of the upper aqueous methanol phase by careful aspiration, followed by tilting of the tube allowing removal of the lower chloroform phase in a similar fashion. For size exclusion HPLC of the full-length protein, the pellet was air dried for 1-2 min with the tube inverted and resuspended in 90% formic acid. For cleavage of the protein, after drying the pellet it was resuspended in a saturated solution of CNBr in 90% formic acid and left for 2 h in the dark. Formic acid was removed in a vacuum centrifuge, and the pellet was left in 0.5 ml of 0.1% trifluoroacetic acid in water overnight. The sample was dried again and resuspended in 60% formic acid immediately prior to RP-HPLC. HPLC-For final purification of EmrE after covalent modification with DiPC, HPLC was used prior to ESI-MS in an in-line setup (liquid chromatography/MS). To separate the CNBr peptides generated from EmrE, a polystyrene/divinylbenzene column (PLRP/S, Polymer Labs, 5 M, 300 Å, 150 mm ϫ 2.1 mm) at 40°C was used for reverse phase liquid chromatography/MS (23) . Following equilibration in 95% solvent A:5% solvent B for 5 min (solvent A, 0.1% trifluoroacetic acid in water; solvent B, 0.1% trifluoroacetic acid in CH 3 CN:isopropanol (1:1) ), the percentage of solvent B was increased to 40% over the next 25 min and further to 100% B over the subsequent 120 min at a flow rate of 0.1 ml/min. All chromatographic separations were performed at 40°C using a modified ABI 120A dual-syringe pump HPLC equipped with a post-detector (A 280 ) splitter for back pressure regulation.
Electrospray Ionization Mass Spectrometry-ESI-MS was performed using a PerkinElmer Sciex API III triple-quadrupole instrument operating in the positive ion mode as described. The orifice potential was 75 V for full-length EmrE and ramped from 60 to 120 V across the mass range (600 -2300) for CNBr fragments. MS/MS spectrometry fragment ion spectra were obtained by splitting the flow into the API-III during RP-HPLC and collecting peptides of interest for infusion (3 l/min) into a ThermoFinnigan LCQ Deca ion trap instrument with a 33-gauge stainless steel needle source at 3.3 kV. The nomenclature used for fragment ions is N-terminal fragments (b type) and C-terminal fragments (y type).
RESULTS

ESI-MS of EmrE-Following electrospray ionization, EmrE
ions carrying from 7 to 16 positive charges (H ϩ ) are readily detected (Fig. 1C) . Molecular mass reconstruction of wild type EmrE with a carboxyl-terminal Myc-and His 6 tag reveals that 
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the EmrE gene product is homogeneous and that the computed mass (15, 192 Da) matches closely that calculated from the DNA sequence (Fig. 1D, 15,192 Da). However, because of the harsh resolubilization regimen (90% formic acid), there is also a formylation adduct (15,219 Da).
Identification of the Glu-14-containing CNBr Fragment by ESI-MS/MS-Previous studies indicate that
Glu-14 is covalently modified by hydrophobic carbodiimides leading to inactivation of EmrE (13) . Because wild type EmrE has 10 carboxyl group-containing side chains (7 of them in the Myc-His tag), to quantify the extent of carbodiimide modification of Glu-14 EmrE was cleaved with CNBr ( Fig. 2A) . The resultant peptides ( Fig. 2A) were resolved by RP-HPLC in-line with ESI-MS as described under "Materials and Methods," revealing a peptide with a measured monoisotopic mass ([MϩH] ϩ ) of 2061 Da, which is in close agreement with that calculated (2061.l Da). Notably, most of the observed ion current existed in a doubly charged state at m/z 1031.9. Collisionally activated dissociation of the doubly charged parent ion revealed fragment ions consistent with the sequence 2 NPYIYLGGAILAE-VIGTTLM 21 ( Fig. 2B) . TPP ϩ Protectable Modification of Glu-14 by DiPC-The reaction of a carbodiimide with a carboxyl group leads to the formation of a protonated O-acylisourea that rearranges to form a stable N-acylisourea with no further change in mass (Refs. 24, 25 and Fig. 3A) . Following reaction of EmrE with DiPC, RP-HPLC-ESI-MS of CNBr fragments resolved by RP-HPLC revealed a doubly charged parent ion at m/z 1094.9 corresponding to a molecule of molecular mass 2187.8 Da with a measured 126.7 Da mass increase (Fig. 3B, compare I and II) . Collision-activated dissociation of the doubly charged parent ion at m/z 1094.9 revealed fragment ions consistent with the sequence 2 NPYIYLGGAILAEVIGTTLM 21 modified at position 14 by DiPC (data not shown). Notably, reaction of EmrE with a 10-fold higher concentration of the hydrophilic carbodiimide EDAC leads to only ϳ8% modification of Glu-14 over an extended time period (Fig. 4A, II, 120 min) , demonstrating once again that hydrophobicity of the reagent governs access to Glu-14.
Previously published results (13) demonstrate that substrates protect EmrE from inhibition by hydrophobic carbodiimides, and the results presented here by RP-HPLC in-line with ESI-MS reveal that TPP ϩ protects EmrE by reducing the amount of modification of Glu-14 by DiPC (Fig. 3B , compare II and III). At pH 6.5, DiPC reacts in a concentration-dependent manner with the carboxyl group of Glu-14 and the reaction terminates at ϳ80% modification, most probably because of the instability of carbodiimides in aqueous solution (Fig. 4A, I ). This information identified the linear range of DiPC modification and served as the foundation of a quantitative experiment using different concentrations of TPP ϩ . Although the experimental setup did not allow the use of EmrE concentrations lower that 40 M, thus preventing us from studying the concentration dependence of TPP ϩ protection against DiPC modification at low concentrations, higher concentrations of TPP ϩ clearly reduce the extent of DiPC modification by ϳ80% (Fig. 4B) . DISCUSSION Previously, carbodiimide modification of EmrE has been studied using functional assays monitoring EmrE inactivation. Two lines of evidence suggest that Glu-14 is the target of this carbodiimide-mediated inactivation: (i) EmrE is inactivated by hydrophobic, but not hydrophilic, carbodiimides; (ii) an EmrE mutant possessing a single carboxyl at position 14 is inhibited by dicyclohexylcarbodiimide in a similar manner to wild type. A remarkable aspect of the inhibition is that it can be virtually completely prevented by substrates of EmrE. Now, by exploiting ESI-MS, it is possible to monitor the reaction of carbodiimide with each EmrE monomer directly rather than following inactivation of the functional unit.
Practically all (ϳ80%) of the detergent-solubilized EmrE is covalently modified by the hydrophobic carbodiimide DiPC. CNBr cleavage of EmrE reveals that DiPC reacts extensively with the peptide containing Glu-14, leading to the expected change in mass because of the formation of an N-acylurea. In contrast, as expected from functional studies (13), the hydrophilic carbodiimide EDAC fails to react significantly at concentrations up to 10-fold higher (20 mM). Because the carbodiimide moiety reacts with the protonated form of a carboxyl group, it is concluded that all Glu-14 residues in the EmrE functional unit are accessible to DiPC, inaccessible to EDAC, and predominantly protonated at pH 6.5. These findings agree with previous studies demonstrating that Glu-14 is buried with an anomalously high pK a of ϳ8.5 (26) . Furthermore, the observation that Glu-14 is accessible to relatively large bulky hydrophobic reagents (e.g. dicyclohexylcarbodiimide, DiPC), but inaccessible to similarly sized hydrophilic reagents (e.g. EDAC), strengthens the hypothesis that Glu-14 is located inside a large hydrophobic drug binding pocket. Interestingly, EmrE mutants with either (E25C or D84C) or both (single carboxyl-EmrE) of 
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the carboxyl residues located in the loops removed undergo DiPC modification in a fashion very similar to the wild type EmrE, supporting the idea that the Glu-14 carboxyl is not networked with other acidic residues (data not shown).
Structural evidence from two-dimensional crystals led to the proposal that the minimal functional unit of EmrE was likely to be a dimer (27) . This was confirmed by determination of the three-dimensional structure of EmrE with TPP ϩ bound at 7.5 Å resolution by electron cryomicroscopy of two-dimensional crystals (9) . The minimal structural unit is an asymmetric homodimer composed of 8 transmembrane ␣-helices, i.e. 4 helices from each monomer, with density for TPP ϩ in a binding chamber formed from 6 of the 8 ␣-helices, confirming the suggestion that TPP ϩ binds near the center of the dimer (9) . However, these findings do not rule out the existence of higher order oligomers. In fact, co-expression of two plasmids in a cell-free system allowed demonstration of functional complementation, and pulldown experiments suggested that the basic functional unit is the dimer (7), whereas additional weak interactions between dimers detected using cross-linking implies the existence of a dimer of dimers (7) .
Based on crystals of EmrE that diffract to 3.8 Å, an atomic model was recently proposed by Ma and Chang (19) . In this model, the structure of EmrE is a tetramer composed of two conformational heterodimers related by a pseudo 2-fold symmetry axis perpendicular to the membrane surface. In each 
conformational heterodimer, the Glu-14 residues are in a different environment, one solvent exposed while the other lies in a putatively hydrophobic environment. A transport mechanism is suggested in which the functional unit is a tetramer formed by two heterodimers. Within each heterodimer, one Glu-14 takes part in drug binding while the other is responsible for proton translocation resulting in coupling of the drug and proton fluxes (Fig. 5, Model I) . Critically, such a model indicates that there are two equally sized subpopulations of Glu-14 carboxyls, each residing in a significantly different environment, most likely with different pK a and accessibility to DiPC, EDAC, TPP ϩ . However, the results of this study indicated that ϳ80% of Glu-14 are modified by DiPC and, similarly, TPP ϩ protects against ϳ80% of this modification, suggesting that the Glu-14 residues in the functional unit of EmrE are functionally equivalent, playing a direct role in substrate binding.
Finally, previous studies demonstrate that practically all (Ͼ80%) the EmrE monomers release a proton from the Glu-14 carboxyl upon substrate binding (26) , implying that both Glu14s in the EmrE dimer are involved in proton binding and release. Furthermore, an proton-substrate antiport studied in proteoliposomes was found to be electroneutral for doubly charged substrates and electrogenic for singly charged substrates (28) . These findings led to the conclusion that two protons are exchanged with one substrate molecule in each transport cycle. Taken together, the results support a model (Fig. 5, Model II) 
